VCMCVC Market Cap
Menu

Funding round

Inari Series E

Inari, which works in seed design and breeding technology development in Cambridge, raised $124M in a Series E round announced on 4 Oct 2022, led by Canada Pension Plan Investment Board and Flagship Pioneering, at a $1.50B post-money valuation. 6 firms took part, 4 of them already investors. It is Inari's fourth venture round on record; the one before was a Series D in May 2021.

Inari Biotechnology

$124M

Amount raised

$1.50B

Post-money valuation

6

Investors

2 leads

1.3x

Step-up from the Series D

$1.20B in May 2021

8.3%

Stake sold

new money over the post-money

Valuation

What this round says about the price

This round priced Inari at $1.50B after the new money, 1.3 times the $1.20B of its Series D (May 2021). The $124M bought investors about 8.3% of the company. It came 17 months after Inari's Series D. It is 18% of the $708M Inari has raised in the venture rounds on record. Inari raised again 15 months later: a Growth round of $103M in Jan 2024, at $1.65B post-money.

Inari's funding rounds

Inari has 6 venture rounds on record and 1 other deal. This one is highlighted.

  1. Series B 9 Aug 2018, led by Flagship Pioneering $40M
  2. Series C 6 Aug 2019 $89M
  3. Debt not a venture round 22 Apr 2020 $45M
  4. Series D 12 May 2021, led by Flagship Pioneering and Alexandria Venture Investments $208M$1.20B post-money
  5. Series E this round 4 Oct 2022, led by Canada Pension Plan Investment Board and Flagship Pioneering $124M$1.50B post-money
  6. Growth 30 Jan 2024 $103M$1.65B post-money
  7. Growth 7 Jan 2025 $144M

Investors

Who put money in

Canada Pension Plan Investment Board and Flagship Pioneering led the round with 4 other firms. Flagship Pioneering, Hanwha Impact, NGS Super and Banque Pictet had backed Inari before.

Lead investors

  • Canada Pension Plan Investment Board new investor
  • Flagship Pioneering existing investor

Also in the round

  • backs 3 venture-backed companies existing investor
  • NGS Super existing investor
  • Banque Pictet existing investor
  • backs 3 venture-backed companies new investor

Use of proceeds

What the money is for

According to the announcement, the money goes to product development, geographic expansion, scaling operations and working capital.

  • Product development
  • Geographic expansion
  • Scaling operations
  • Working capital

Comparable rounds

How it compares

The closest in time: 1 in Biotechnology, then Series E rounds in any sector within 6 months:

Comparable rounds
CompanyAnnouncedAmountPost-moneyLed by
Biotechnology4 Jul 2022$150Mnot disclosedLegend Capital
Form Energy Batteries4 Oct 2022$450Mnot disclosedTPG
Airwallex Payment Processing & Point of Sale10 Oct 2022$100M$5.50Bnot named
Property Management19 Oct 2022$98Mnot disclosed83North
Maven Clinic Health Care Services1 Oct 2022$90M$1.35BGeneral Catalyst
Tech Companies22 Oct 2022$75M$867Mnot named
Alan Insurance - Agents, Carriers & Brokers12 Oct 2022undisclosednot disclosednot named
Business Consulting6 Sep 2022$318Mnot disclosedTHE FUND

Sources

Where this comes from

Reported by 5 sources.

Questions

Frequently asked

How much did Inari raise in its Series E round?

Inari raised $124M in its Series E round, announced in Oct 2022.

Who led Inari's Series E round?

Canada Pension Plan Investment Board and Flagship Pioneering led it, with Hanwha Impact, NGS Super, Banque Pictet and Sage Hill Investors.

What was Inari's valuation at the Series E round?

$1.50B post-money.

Did Inari raise again after this round?

Yes: a Growth round in Jan 2024 of $103M at $1.65B post-money.